NCT06646783 2024-10-17
Phase IIT Trial of SNA014
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
7 trialsNCT05715931 2024-09-19
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT03647969 2024-08-09
Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT05970627 2023-08-01
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
First Affiliated Hospital of Zhejiang University
Phase 2 Not yet recruiting
NCT04077255 2022-11-30
EGFR-targeted Therapy for Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT02202759 2017-05-15
A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction
Takeda
Phase 2 Terminated
NCT01095120 2012-03-15
Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer
Genta Incorporated
Phase 2 Unknown